Gaudium IVF Board Approves Q4 & FY26 Audited Financial Results

Gaudium IVF and Women Health Limited's Board of Directors, at its meeting on May 28, 2026, approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The results were accompanied by an unmodified auditor's report issued by S K G N & Associates LLP, the company's Statutory Auditors. In compliance with SEBI regulations, the trading window for designated persons and their immediate relatives remains closed up to and including May 30, 2026. The disclosure will also be hosted on the company's website.